Scientists warn $1 billion push for “implementation science” spurred by promise of lenacapavir will hurt research on new treatments and vaccines



Summary

Scientists are raising concerns that a $1 billion investment in “implementation science,” driven by the promising HIV drug lenacapavir, will stifle innovation in new HIV treatments and vaccines. This funding shift prioritizes delivering existing solutions over exploring novel research avenues. Critics argue that while ensuring access to effective drugs like lenacapavir is crucial, neglecting basic research could ultimately limit future advancements and potentially delay the discovery of even more effective preventative or curative strategies for HIV.

Read more…

Credits: Source

This post is part of “Science/Immunology News”, Follow for more…!!!